Reversal of Major Genotypic Tipranavir Mutations Under Long-Term Treatment with Tipranavir/Ritonavir Itself with Very Limited Optimized Background, During Deep Salvage Antiretroviral Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|7|3|311-313

ISSN： 1570-162X

Source： Current HIV Research, Vol.7, Iss.3, 2009-05, pp. : 311-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 425-433

Bentham Science Publishers

Access to resources Recommend Favorite

Susceptibility of HIV-1 to Tipranavir and Other Antiretroviral Agents in Treatment-Experienced Patients: The UTILIZE Study

By  

Current HIV Research, Vol. 8, Iss. 4, 2010-06 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers

By  

Current HIV Research, Vol. 9, Iss. 4, 2011-06 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite

In utero exposure to antiretroviral therapy: feasibility of long-term follow-up

By Hankin Claire   Lyall Hermione   Willey Barbara   Peckham Catherine   Masters Janet   Tookey Pat  

AIDS Care, Vol. 21, Iss. 7, 2009-07 ,pp. : 809-816

Routledge Ltd

Access to resources Recommend Favorite

Long-Term Medication Adherence in Patients Receiving Antiretroviral Drug Therapy

By  

Current HIV Research, Vol. 9, Iss. 4, 2011-06 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite